Shangkun Zhang

Statistics

Publications

Citations

857

H-Index

Active since

2019

Affiliations

Wuhan University of Science and Technology(Current)

Tongji Hospital

Wuhan Institute of Bioengineering

Huazhong University of Science and Technology

Hubei Provincial Center for Disease Control and Prevention

Shangkun Zhang is an author at Wuhan University of Science and Technology specializing in immunotherapy, chimeric antigen receptor t-cell therapy, and cancer immunotherapy.

ORCID

Publications per year

2019–2024

Publications

Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies

Na Wang, Xuelian Hu, Wenyue Cao et al. · Blood · 2019 · 264 citations · Full text

Medicine, Hematology, Immunology +12

Physical model test and numerical simulation on the failure mechanism of the roadway in layered soft rocks

Xiaoming Sun, Chengwei Zhao, Yong Zhang et al. · International Journal of Mining Science and Technology · 2021 · 84 citations · Full text

Engineering, Civil Engineering, Geological Engineering +16

A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia

Chunrui Li, Wenyue Cao, Yimei Que et al. · Clinical and Translational Medicine · 2021 · 69 citations · Full text

Medicine, Hematology, Oncology +16

CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas

Yang Cao, Yi Xiao, Na Wang et al. · Transplantation and Cellular Therapy · 2021 · 64 citations · Full text

Medicine, Hematology, Oncology +15

Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT

Jia Wei, Min Xiao, Zekai Mao et al. · Signal Transduction and Targeted Therapy · 2022 · 62 citations · Full text

Medicine, Immunology, Oncology +15

1–5 of 15